x

Search for a clinical trial

* (*) mandatory field

127 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member =

National clinical trial(s)

FINLAND

Finland
HELSINKI

BNCT to treat glioma that has progressed following radiotherapy
HUCH - Helsinki University Central Hospital
Department of Oncology

FRANCE

AUVERGNE-RHONE-ALPES
BRON

Recruiting trial
Ongoing trial
Randomized, Prospective, Multicenter Blinding Singles With Arm A and Arm B Innovative Strategy Strategy Conventional (Phase III) - FR
CHU de Lyon HCL - GH Est-Hôpital Neurologique P. Wertheimer
Neurochirurgie B - Unité multidisciplinaire de Chirurgie Tumorale de la base du Crâne

FRANCE

BRETAGNE
RENNES

FRANCE

ILE-DE-FRANCE
BOBIGNY

A Phase II multicenter study of immunotherapy with CpG-ODN in patients with glioblastoma -Terminated -
CHU Paris Seine-Saint-Denis - Hôpital Avicenne
Service de neurologie

FRANCE

ILE-DE-FRANCE
BOBIGNY

Randomized Phase III Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma - Terminated -
CHU Paris Seine-Saint-Denis - Hôpital Avicenne
Service de neurologie

FRANCE

ILE-DE-FRANCE
BOBIGNY

Glivec - Hydrea in recurrent glioblastoma (Phase II) - Terminated -
CHU Paris Seine-Saint-Denis - Hôpital Avicenne
Service de neurologie

FRANCE

ILE-DE-FRANCE
BOBIGNY

Recruiting trial
Radiotherapy and Temozolomide with or without Avastin for treatment of de novo glioblastoma (Phase III)
CHU Paris Seine-Saint-Denis - Hôpital Avicenne
Service de neurologie

FRANCE

ILE-DE-FRANCE
PARIS

EORTC protocol 26083 : Randomized phase II of CCNU (Lomustine) versus CCNU (Lomustine) - dasatinib in patients with recurrent glioblastoma
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Unité Fonctionnelle Epilepsie

FRANCE

ILE-DE-FRANCE
PARIS

Chemotherapy study of temozolomide-bevacizumab treatment of supratentorial glioblastoma patients more than 70 years old with altered functional state (Phase II).
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Département de Neurologie 2 (Mazarin) : Neuro-Oncologie

FRANCE

ILE-DE-FRANCE
PARIS

Phase III study chemotherapy vs radiotherapy in low-grade glioma
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Département de Neurologie 2 (Mazarin) : Neuro-Oncologie

FRANCE

ILE-DE-FRANCE
PARIS

Recruiting trial
Ongoing trial
A Prospective, Multi-center Phase III Trial of NovoTTF-100A Together With Temozolomide Compared to Temozolomide Alone in Patients With Newly Diagnosed Glioblastoma Multiforme
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Département de Neurologie 2 (Mazarin) : Neuro-Oncologie

FRANCE

ILE-DE-FRANCE
PARIS

Recruiting trial
Multicentric Randomized Phase II: Immunotherapy With CpG-ODN in Malignant Glioblastoma
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Consultation de Neurochirurgie

FRANCE

OCCITANIE
TOULOUSE

PhaseI-II trial to assess the radiosensitizing effect of Zarnestra in patients with glioblastoma multiforme
IUCT Oncopole - CLCC Institut Claudius Regaud
Département de radiothérapie

FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

A randomized multicentric phase II trial immunotherapy of de novo glioblastoma by CpG-ODN
CHU de Marseille - Hôpital de la Timone
Service de neuro-oncologie

GERMANY

Baden-Württemberg
HEIDELBERG

GERMANY

Baden-Württemberg
HEIDELBERG

GERMANY

Baden-Württemberg
HEIDELBERG

GERMANY

Baden-Württemberg
ULM

GERMANY

Bayern
MÜNCHEN

Recruiting trial
Ongoing trial
GlioCave/NOA17: Adjuvant Stereotactic Fractionated Radiotherapy to the Resection Cavity in Recurrent Glioblastoma (Phase 2) - DE
Klinikum rechts der Isar der Technischen Universität München
Klinik und Poliklinik für RadioOnkologie und Strahlentherapie

GERMANY

Hessen
FRANKFURT AM MAIN

NETHERLANDS

Limburg
MAASTRICHT

NETHERLANDS

Noord-Holland
AMSTERDAM

SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

SPAIN

Navarra
PAMPLONA

Phase II study of neoadjuvant nivolumab in patients with glioblastoma multiforme - ES (completed)
CIMA - Centro de Investigación Médica Aplicada
Área de Terapia Génica y Hepatología

SWITZERLAND

Suisse Alémanique
ZÜRICH

Avastin Plus Radiotherapy in Elderly Patients With Glioblastoma (ARTE)
University Hospital Zurich
Department of Neurology

UNITED KINGDOM

Greater London
LONDON

SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

GERMANY

Bayern
REGENSBURG

GERMANY

Nordrhein-Westfalen
BONN

FRANCE

AUVERGNE-RHONE-ALPES
LYON

FRANCE

ILE-DE-FRANCE
PARIS

Recruiting trial
Ongoing trial
A Study Evaluating Dexamfetamine Sulphate in Patients With Glioma Suffering From Severe Asthenia. A Phase III Double-blind Randomized Placebo-controlled Trial
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Unité Fonctionnelle Epilepsie

FRANCE

ILE-DE-FRANCE
VILLEJUIF

Recruiting trial
Ongoing trial
BIOMEDE: Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication (Phase II) - FR
CLCC Institut Gustave Roussy
Département de cancérologie de l'enfant et de l'adolescent #

FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

GERMANY

Niedersachsen
GÖTTINGEN

NETHERLANDS

Zuid-Holland
LEIDSCHENDAM

Cognitieve Rehabilitatie van Glioom Patiënten
HMC - Haaglanden Medisch Centrum, locatie Antoniushove
Polikliniek Neurologie

UNITED KINGDOM

Tyne & Wear
NEWCASTLE UPON TYNE

CNS 2007 04: A Phase II Multi-Centre Study of Concomitant and Prolonged Adjuvant Temozolomide With Radiotherapy in Diffuse Pontine Gliomas - UK (Completed)
The Great North Children's Hospita, Royal Victoria Infirmary
Sir James Spence Institute of Child Health

UNITED KINGDOM

Greater Manchester
NOT YET IDENTIFIED - UK

Multinational clinical trial(s)

GERMANY

Baden-Württemberg
TÜBINGEN